These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 2168299

  • 21. Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects.
    Takada H, Kishimoto C, Hiraoka Y.
    Circulation; 1995 Sep 15; 92(6):1604-11. PubMed ID: 7664447
    [Abstract] [Full Text] [Related]

  • 22. Failure of treatment with interleukin-2 receptor-specific monoclonal antibody in acute coxsackievirus B3 myocarditis in mice.
    Kishimoto C, Hiraoka Y, Takada H, Kurokawa M, Ochiai H.
    Heart Vessels; 1997 Sep 15; 12(5):221-8. PubMed ID: 9846807
    [Abstract] [Full Text] [Related]

  • 23. Initial weight and virus dose: two factors affecting the onset of acute coxsackievirus B3 myocarditis in C57BL/6 mouse--a histopathology-based study.
    Li M, Wang X, Xie Y, Xie Y, Zhang X, Zou Y, Ge J, Chen R.
    Cardiovasc Pathol; 2013 Sep 15; 22(1):96-101. PubMed ID: 22784985
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis.
    Costanzo-Nordin MR, Reap EA, O'Connell JB, Robinson JA, Scanlon PJ.
    J Am Coll Cardiol; 1985 Nov 15; 6(5):1078-82. PubMed ID: 2995470
    [Abstract] [Full Text] [Related]

  • 30. Lymphokine activated killer cells in murine coxsackievirus B3 myocarditis.
    Kishimoto C, Kuroki Y, Kurokawa M, Ohiai H.
    Basic Res Cardiol; 1997 Dec 15; 92(6):402-9. PubMed ID: 9464864
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Colony-stimulating factors and coxackievirus B3 myocarditis in mice: macrophage colony-stimulating factor suppresses acute myocarditis with increasing interferon-alpha.
    Hiraoka Y, Kishimoto C, Takada H, Suzaki N, Shiraki K.
    Am Heart J; 1995 Dec 15; 130(6):1259-64. PubMed ID: 7484779
    [Abstract] [Full Text] [Related]

  • 33. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
    Schmidtke M, Glück B, Merkle I, Hofmann P, Stelzner A, Gemsa D.
    J Med Virol; 2000 Aug 15; 61(4):518-26. PubMed ID: 10897072
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Intracardiac thrombus in murine Coxsackievirus B3 myocarditis.
    Kishimoto C, Ochiai H, Sasayama S.
    Heart Vessels; 1992 Aug 15; 7(2):76-81. PubMed ID: 1328146
    [Abstract] [Full Text] [Related]

  • 37. Effect of delayed captopril therapy on left ventricular mass and myonecrosis during acute coxsackievirus murine myocarditis.
    Rezkalla S, Kloner RA, Khatib G, Khatib R.
    Am Heart J; 1990 Dec 15; 120(6 Pt 1):1377-81. PubMed ID: 2174203
    [Abstract] [Full Text] [Related]

  • 38. The effect of subsequent myocardial damage on the expression of coxsackievirus B4 myocarditis and the development of ventricular aneurysms.
    Khatib R, Khatib G, Reyes MP, Giraldo A.
    Eur Heart J; 1994 Aug 15; 15(8):1140-3. PubMed ID: 7988609
    [Abstract] [Full Text] [Related]

  • 39. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
    Yun SH, Lee WG, Kim YC, Ju ES, Lim BK, Choi JO, Kim DK, Jeon ES.
    J Infect Dis; 2012 Feb 01; 205(3):491-7. PubMed ID: 22207647
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.